DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer

BACKGROUND: The 5-year survival rate of patients with hepatocellular cancer (HCC) was very low because of invasion and metastasis in the early stage. Biomarkers might help predict early occurrence of invasion and metastasis. Accumulating evidence has shown that deleted in liver cancer-1 (DLC1) may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, L. J., Liu, Q., Meng, X. R., Li, SH. L, Wang, L. X., Fan, Q. X., Xuan, X. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743322/
https://www.ncbi.nlm.nih.gov/pubmed/26846339
http://dx.doi.org/10.1186/s13000-016-0470-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743322/
https://www.ncbi.nlm.nih.gov/pubmed/26846339
http://dx.doi.org/10.1186/s13000-016-0470-x

Ejemplares similares